Home Life Sciences A multiplicative behavioral model of DNA replication initiation in cells
Article Open Access

A multiplicative behavioral model of DNA replication initiation in cells

  • Tahir Rahman ORCID logo EMAIL logo
Published/Copyright: December 30, 2025

Abstract

DNA replication is a precisely timed cellular decision rather than a continuous biochemical process. Despite extensive mechanistic detail, no unified framework quantitatively explains how structural, metabolic, chromatin, and phase-dependent factors converge to initiate replication. Here, we introduce the ARCH × Φ model, which defines replication onset as a multiplicative threshold event integrating structural, metabolic, chromatin, and phase-control domains. Derived from the recently formalized ARCH behavioral framework, the model expresses replication initiation as R = Φ(A × D × C), where A denotes the origin-licensing architecture, D the metabolic and kinase drives, C the chromatin context, and Φ the phase-control term governing cell-cycle permissiveness. The model predicts (i) all-or-none S-phase entry, (ii) synergistic inhibition when multiple pathways are partially reduced, and (iii) reversible arrest through checkpoint-mediated suppression of Φ. A simple mathematical formulation enables stability analysis and simulation using standard nonlinear control methods. The framework can be falsified by perturbation-matrix experiments measuring whether replication onset scales multiplicatively rather than additively with A, D, and C. By formalizing replication as a threshold-governed system, ARCH × Φ links molecular control of genome duplication with broader principles of biological decision-making, providing a quantitative bridge between cell-cycle dynamics and systems theory.

1 Introduction

The accurate duplication of genetic material is among the most fundamental and evolutionarily conserved events in biology. DNA replication does not occur continuously but initiates with precise spatial and temporal regulation, ensuring that each genome locus is copied once – and only once – during each cell cycle [1]. Since the elucidation of the double-helical structure of DNA by Franklin, Watson and Crick [2], biologists have sought to understand how cells determine when and where replication begins, and how this decision integrates molecular architecture, metabolic readiness, and chromatin context.

Early models, such as the replicon theory of Jacob, Brenner, and Cuzin [3], formalized the concept of discrete origin sites that license the initiation of replication. Subsequent decades of molecular dissection have described the proteins and checkpoints governing this process, yet a unifying theoretical framework remains lacking. Current descriptions are often modular – treating origin licensing, cyclin-dependent kinase activation, and chromatin accessibility as independent control layers – without a single formalism explaining their convergence.

Recent theoretical work has sought to represent cellular decisions as threshold-governed phenomena rather than linear sequences [4], 5]. Building on this perspective, the present study extends the ARCH framework, which has recently been formalized as a neuro-evolutionary model of behavioral execution [6]. The ARCH model posits that any organized biological action arises only when four essential conditions align above a critical threshold: Archetype, the structural architecture enabling the act; Drive, the energetic or motivational impetus; Culture, the contextual or environmental modulation; and Φ, a phase-control or homeostatic term representing baseline permissiveness. This framework is illustrated in Figure 1.

Figure 1: 
Conceptual structure of the ARCH × Φ model for replication initiation. Replication occurs only when four readiness domains converge above a critical threshold: A (Archetype) – structural and molecular licensing architecture (ORC, MCM, Cdc6); D (drive) – metabolic and kinase readiness (CDK activity, ATP/dNTP availability); C (Culture) – chromatin accessibility and 3D genome topology (H3K4me3-enriched, H3K9me3-repressed domains); Φ (phase control) – global cell-cycle permissiveness integrating checkpoints and G
1/S transition status. Replication initiation occurs only when Φ(A × D × C) exceeds the threshold T, unifying architectural, energetic, contextual, and temporal determinants within a single quantitative framework.
Figure 1:

Conceptual structure of the ARCH × Φ model for replication initiation. Replication occurs only when four readiness domains converge above a critical threshold: A (Archetype) – structural and molecular licensing architecture (ORC, MCM, Cdc6); D (drive) – metabolic and kinase readiness (CDK activity, ATP/dNTP availability); C (Culture) – chromatin accessibility and 3D genome topology (H3K4me3-enriched, H3K9me3-repressed domains); Φ (phase control) – global cell-cycle permissiveness integrating checkpoints and G 1/S transition status. Replication initiation occurs only when Φ(A × D × C) exceeds the threshold T, unifying architectural, energetic, contextual, and temporal determinants within a single quantitative framework.

Here, this behavioral grammar is translated from higher-order systems to the molecular domain of DNA replication. The model presented herein hypothesizes that the initiation of genome duplication obeys the same conjunctive threshold logic: replication occurs only when structural (A), metabolic (D), chromatin (C), and phase-dependent (Φ) requirements converge above a minimal product value. This formulation models replication initiation as a multiplicative function of structural, metabolic, chromatin, and phase-readiness factors. The following sections formalize this model, define measurable correlates of each component, and outline its explanatory and predictive implications for replication timing, checkpoint control, and cellular variability.

2 Theoretical framework: the ARCH × Φ model

2.1 Conceptual basis

Replication initiation can be regarded as a decision-making process in which the cell integrates multiple forms of readiness before executing genome duplication. Analogous threshold behavior is well established in physiology and neuroscience [7], 8]. The ARCH × Φ framework applies this logic to replication, representing it as a conditionally gated system whose activation depends on the multiplicative conjunction of four control domains. The model extends the generalized ARCH principle [6], formulated initially to describe neural behavioral execution, to the cellular scale. In both cases, an act occurs only when preconditions in structure, energy, context, and global permissiveness align. This conceptual transfer provides a unifying language linking behavioral, cellular, and molecular decision systems.

2.2 Formal definition

Let A, D, C, and Φ denote normalized variables representing, respectively:

  1. A (Archetype): structural and molecular licensing architecture, including origin recognition complexes (ORC), minichromosome maintenance (MCM) helicases, and associated loading factors [9], 10].

  2. D (Drive): metabolic and signaling readiness – principally cyclin-dependent kinase activity, nucleotide availability, and energy state [11], 12].

  3. C (Culture): chromatin accessibility and nuclear topology defining the contextual permissiveness of origins [13], 14].

  4. Φ (Phase Control): global cell-cycle permissiveness integrating checkpoint status and phase readiness [15].

Replication initiation (denoted R init) occurs when: R init = Φ(A × D × C) ≥ T, where T is a threshold constant representing the minimum combined readiness required for initiation. If any component approaches zero, the product is nullified – that is, Φ(A × D × C) falls below T – and replication initiation is categorically blocked. This conjunctive logic reproduces the empirically observed “all-or-none” behavior of S-phase entry [16]. A detailed derivation of this equation, its normalization procedure, and its stability properties are provided in Appendix A, which formalizes the mathematical behavior of the ARCH × Φ system.

2.3 Component definitions and correlates

2.3.1 Archetype (A): replication architecture

A quantifies the presence and integrity of licensed origins and associated initiation machinery. Experimentally, A can be estimated by ORC/MCM occupancy, number of pre-replicative complexes, or origin competence assays [9]. Loss-of-function mutations in ORC or cell division cycle 6 (Cdc6) abolish origin firing regardless of signaling state [10].

2.3.2 Drive (D): metabolic and signaling readiness

D captures the cell’s energy and cyclin-dependent kinase (CDK) activity. CDK2 and CDK4/6 activation, adenosine triphosphate (ATP) concentration, and deoxyribonucleotide triphosphate (dNTP) pool size contribute to D [11], 12]. When CDK activity or nucleotide supply is suppressed, initiation fails despite intact licensing.

2.3.3 Culture (C): chromatin context

C denotes chromatin accessibility and nuclear organization. Euchromatic domains (H3K4me3-enriched) correspond to high C; heterochromatin or lamina-associated domains (H3K9me3), heterochromatin protein (HP1) correspond to low C [13], 14]. Chromatin remodeling that increases accessibility can elevate C and advance replication timing.

2.3.4 Phase control (Φ): cell-cycle permissiveness

Φ represents global readiness determined by cell-cycle checkpoints. In G 0 or mitosis, Φ ≈ 0; in late G 1/S, Φ ≈ 1. DNA damage or checkpoint activation transiently reduces Φ by CDK inhibition [15], 17].

2.4 Threshold behavior and convergence

In a hypothetical three-dimensional space with axes A, D, and C, the surface Φ(A × D × C) = T defines the boundary separating replication-competent from non-competent states [13], 14], 16]. This relationship is represented schematically in Figure 2. Increasing Φ (for example, after checkpoint release) lowers this threshold surface, whereas reducing Φ raises it. This schematic representation provides an intuitive map of replication readiness and predicts both synergistic and compensatory relationships among the contributing variables.

Figure 2: 
Conceptual threshold surface Φ(A × D × C) = T separating replication-competent (above) from non-competent (below) states. Increasing Φ (e.g., checkpoint release) lowers the surface, expanding the competent region; reducing Φ raises it.
Figure 2:

Conceptual threshold surface Φ(A × D × C) = T separating replication-competent (above) from non-competent (below) states. Increasing Φ (e.g., checkpoint release) lowers the surface, expanding the competent region; reducing Φ raises it.

Because the ARCH × Φ formulation is multiplicative, the influence of each variable is strictly conjunctive: because the model is multiplicative, loss of any component prevents initiation. If any element – structural (A), metabolic (D), chromatin (C), or phase control (Φ) – is absent or falls below its critical value, the composite product Φ(A × D × C) drops beneath the threshold T, and initiation is categorically blocked (1 × 1 × 0 = 0).

At the molecular level, origin activation entails energy expenditure for both local DNA strand separation (“melting”) and elastic deformation of the surrounding chromatin [10], 13], 14]. These physical transitions define the immediate energetic barrier to initiation, such that the threshold T represents the combined cost of strand separation and bending, overcome only when Φ(A × D × C) provides sufficient energetic drive and structural alignment. In this view, chromatin accessibility (C) modulates both melting and bending energies: open euchromatin lowers the barrier, whereas compact heterochromatin raises it.

3 Model predictions and system behavior

3.1 Threshold-dependent initiation

The ARCH × Φ model predicts that replication initiation behaves as a threshold-governed, all-or-none event. Only when the combined product Φ(A × D × C) exceeds a defined threshold T does genome duplication commence. Because the system is multiplicative, increases in one variable cannot compensate for the absence of another; each domain is a necessary condition for initiation, and the product collapses when any term approaches zero. This conjunctive architecture mirrors experimental observations that origin firing requires simultaneous satisfaction of licensing, metabolic activation, chromatin accessibility, and a permissive cell-cycle phase [9], [10], [11], [12], [13], [14], [15]. Classical cell-fusion experiments showed that G 2 nuclei exposed to S-phase cytoplasm do not re-initiate replication, despite abundant replication factors, because licensed origins are absent (A ≈ 0) [18]. Likewise, hydroxyurea-induced depletion of nucleotide pools or CDK inhibition prevents initiation even with licensed origins and accessible chromatin (D ≈ 0) [11], 19]. Heterochromatin compaction, while leaving A and D intact, suppresses firing of local origins (C ≈ 0) [13]. Each of these conditions exemplifies the rule that replication ceases whenever any component of the multiplicative product approaches zero.

3.2 Synergistic interactions

The multiplicative form inherently encodes synergy among the four variables. Incremental changes in one component can yield nonlinear outcomes when others are near their thresholds. For example, moderate decreases in both D and C together can abolish replication even if neither alone is inhibitory – consistent with supra-additive effects observed during combined CDK inhibition and chromatin compaction [20], 21]. Graphically, this behavior corresponds to a steep, sigmoidal activation surface in ADC space. A deterministic contour plot of Φ(A × D × C) shows a narrow transition region separating quiescent and replicating states. Stochastic sampling of A, D, and C values (e.g., from beta distributions) generates bimodal populations – cells either fully initiate replication or remain inactive – reproducing the experimentally observed bistability of S-phase entry [16], 22].

3.3 Once-per-cycle replication

The model naturally explains the once-per-cycle rule of eukaryotic replication. During the S phase, licensed origins are consumed; consequently, A decreases as replication progresses. As licensed origins are consumed, further initiation ceases. In mitosis, high CDK1 activity suppresses licensing and reduces Φ to ≈0, enforcing a refractory period before relicensing [23]. As the cell exits mitosis, Φ gradually increases, reinstating competence in the next cycle. This interplay between declining A and oscillating Φ reproduces the observed periodicity in replication competence.

3.4 Checkpoint control and stress responses

Checkpoint signaling modulates replication by altering D and Φ. Activation of ATR or ATM in response to DNA damage inhibits CDK2 and stabilizes Cdc6, effectively lowering D and Φ below threshold [24]. Chromatin-based feedback further modulates C, for instance, by recruiting replication timing regulatory factor 1 (Rif1) and protein phosphatase 1 (PP1) complexes that locally suppress origin firing [25]. Such mechanisms map precisely onto the multiplicative structure of the model: checkpoint activation unaligns the required variables, reducing the overall product below T and halting initiation until repair is complete.

3.5 Early versus late S-phase dynamics

Replication timing domains arise from spatial and temporal heterogeneity in C and A. Early replicating euchromatic regions have high C and abundant licensed origins (A ≈ 1). In contrast, late-replicating heterochromatin exhibits lower C and fewer competent origins. Regions with higher A and C values cross the threshold earlier, leading to earlier replication [13], 14], 26]. Temporal modulation of Φ by checkpoint activity can further shift timing globally, explaining stress-induced delays in S-phase progression [24]. In this view, the spatially resolved replication program emerges not from a dedicated timing circuit but from distributed variations in A, D, and C within the same gating equation.

3.6 Population level variability

Because A, D, C, and Φ each fluctuate across single cells, the model predicts a broad yet quantized distribution of replication initiation states within populations. Single-cell analyses have shown discrete clusters of S-phase onset times rather than a continuum [27]. The ARCH × Φ formalism reproduces this pattern: stochastic variation around the threshold creates two dominant states – below-threshold (quiescent or G 1) and above-threshold (S-phase entry). This bistability provides a mechanistic basis for population heterogeneity without invoking additional regulatory layers.

4 Comparative and theoretical context

4.1 Positioning within threshold and control theory

The ARCH × Φ model conceptualizes DNA replication initiation as a nonlinear threshold system governed by multiplicative conditionality. This formulation aligns with established control-theoretic principles of state-dependent switching and threshold-crossing dynamics, in which complex outputs arise only when multiple control variables exceed critical limits [20], 28]. In such systems, equilibrium stability changes abruptly once a control manifold is crossed – a behavior described mathematically as a bifurcation or switching transition [28], 29].

Where traditional molecular models depict replication as a sequence of reactions, ARCH × Φ treats it as a stability problem: replication initiation corresponds to a transition from a non-replicating to a replicating steady state when the product Φ(A × D × C) surpasses T. The multiplicative form imposes conjunctive logic analogous to multi-input control gates in dynamical systems [30]. This framing permits formal stability analysis and simulation using established nonlinear-systems approaches, while remaining faithful to empirical cell-cycle biology.

4.2 Relation to bistable cell-cycle switches

Classical models of the G 1/S transition attribute bistability to feedback between retinoblastoma (Rb) and E2F transcription factors – the Rb–E2F switch [16], 31], 32]. These feedback loops generate hysteresis and irreversible S-phase commitment once CDK activity surpasses a critical threshold. The ARCH × Φ model generalizes this principle: bistability arises not solely from feedback but from multiplicative gating of required inputs. When A and C ≈ 1 and Φ acts as a binary variable, ARCH × Φ collapses to the Rb–E2F switch; when A and C vary continuously, the system defines a multidimensional threshold surface rather than a single critical point. Thus, the model embeds molecular feedback within a broader conjunctive framework that also incorporates architectural and chromatin constraints.

4.3 Relation to stochastic and probabilistic origin-firing models

Existing stochastic models describe origin firing as probabilistic, determined by local origin competence and external modulation [33], 34]. Although these frameworks reproduce genome-wide replication-timing distributions, they assume that variables contribute additively or independently. In contrast, ARCH × Φ introduces conditional multiplicativity: an origin fires only when Φ(A × D × C)_i ≥ T_i. This logic explains the supra-additive inhibition observed when multiple pathways are partially suppressed [21], 35] and provides a mechanistic basis for population-level bistability in single-cell replication timing [27], 36]. In dynamical-systems terms, variations in A, D, and C displace a cell’s state relative to the threshold manifold, and stochastic sampling around this boundary yields the experimentally observed coexistence of early- and late-replicating populations.

4.4 Integration with additive and energy-based frameworks

Additive models approximate replication timing as the sum of chromatin state, origin density, and replication-factor abundance [37]. Although statistically accurate, additive combinations yield linear scaling and cannot produce discontinuous transitions. In contrast, the multiplicative gate in ARCH × Φ introduces nonlinear amplification and saturation – features characteristic of biological switches. Energetically, this corresponds to requiring that the system’s total activation potential, Φ(A × D × C), exceed a threshold, T to initiate replication. Thus, ARCH × Φ provides a biophysically interpretable bridge between empirical regression frameworks and nonlinear control theory.

4.5 Conceptual continuity with the general ARCH framework

The ARCH × Φ model extends the generalized ARCH principle of biological behavior [6], wherein organized actions occur only when architecture, drive, context, and phase align above threshold. Applied to the molecular domain, this same logic governs the cellular decision to replicate. Genome duplication thus fits within a hierarchy of conditionally gated behaviors – neural, cellular, and molecular – described by a shared mathematical grammar. Incorporating control-theoretic stability concepts [28], 29] formalizes this hierarchy: across scales, the shift from inactivity to execution corresponds to crossing a critical manifold in multidimensional parameter space.

5 Applications and case scenarios

5.1 Application of the model to cellular contexts

The ARCH × Φ framework provides a quantitative grammar for diverse replication behaviors across cell types. Parameterizing the model for each component – Archetype, Drive, Culture, and Phase – allows physiological and perturbed states to be represented with measurable correlates [9], [10], [11], [12], [13], [14], [15]. In rapidly dividing embryonic or stem cells, A, D, and C remain near maximal, and Φ is constitutively high due to attenuated checkpoints [26], 38]; the system therefore stays above threshold, supporting continuous or shortened cell cycles. In contrast, quiescent or differentiated cells show reduced D and Φ. Although origins remain licensed (A ≈ 1), replication is suppressed because overall readiness falls below threshold. This distinction explains why replication reactivation in differentiated cells requires metabolic and checkpoint reprogramming.

5.2 DNA-damage and checkpoint inhibition scenarios

During genotoxic stress, ataxia telangiectasia and Rad3-related (ATR) and ataxia telangiectasia mutated (ATM) kinase signaling suppresses cyclin-dependent kinase 2 (CDK2) activity and lowers Φ [24], 25], shifting the system below the initiation threshold even when A and C remain intact. This explains the rapid replication arrest in hydroxyurea-treated or UV-irradiated cells [19], 24]. Recovery of checkpoint control restores CDK activity and raises Φ, allowing replication to resume. Thus, transient stress drives reversible crossing of the threshold manifold: replication halts globally yet reversibly because checkpoint regulation modulates Φ rather than dismantling origin architecture.

5.3 Early-versus late-S-phase domains

Spatial variation in A and C underlies the biphasic pattern of S-phase replication [13], 14], 26]. Euchromatic regions (C ≥ 0.7) with dense licensed origins (A ≈ 1) reach the threshold first and replicate early, whereas heterochromatin (C ≤ 0.3, A < 0.5) requires stronger Drive and Phase permissiveness to fire later. Checkpoint-mediated reductions in Φ shift this timing curve globally, delaying both domains. Replication timing, therefore, emerges as a distributed property of the same multiplicative gate rather than from a dedicated temporal controller.

5.4 Bulk-population versus single-cell predictions

In multicellular contexts, intercellular signaling and proximity add a layer of modulation: neighboring cells can influence each other’s metabolic drive, chromatin state, and checkpoint control. This coupling extends the ARCH × Φ framework from single-cell dynamics to collective behavior, allowing replication readiness to propagate across populations. Because A, D, C, and Φ fluctuate among cells, the model predicts heterogeneity even in genetically identical cultures. Stochastic variation in these components determines whether an individual cell surpasses the replication threshold, generating bimodal – replicating or quiescent – states consistent with single-cell Repli-Seq data [27], 36]. At the bulk level, ensemble averaging of these binary states produces apparent gradients in replication probability, reconciling population and single-cell observations without invoking separate regulatory programs.

5.5 Model-based experimental design

The framework suggests direct perturbation experiments for empirical validation. A three-factor design varying origin licensing, kinase activity, and chromatin accessibility can map the predicted threshold surface:

  1. A modulation – partial ORC or MCM depletion;

  2. D modulation – CDK2 inhibition or nucleotide depletion;

  3. C modulation – histone-deacetylase inhibition or heterochromatin tethering.

Replication output measured by bromodeoxyuridine (BrdU) incorporation or single-cell sequencing should display multiplicative – not additive – suppression. Combined partial perturbations (e.g., 50 % reduction in D plus 50 % reduction in C) are expected to produce supra-additive inhibition, providing a clear test of the model’s conjunctive logic.

5.6 Translational implications

Many cancer cells exhibit chronically high D from oncogenic signaling and impaired checkpoint control, yielding Φ ≈ 1 but defective A and C due to licensing stress and chromatin instability [39], 40]. The ARCH × Φ framework interprets this as a misaligned state in which excessive D and Φ sustain replication above threshold despite structural and chromatin deficits, promoting genomic instability. Therapeutic strategies that rebalance these parameters – such as concurrent CDK inhibition (reducing D) and chromatin-stabilizing agents (restoring C) – could selectively reduce tumor cell replication competence while sparing normal tissues. This reasoning quantitatively explains the synergy of combined cell-cycle and epigenetic interventions [41] and links the model’s parameters to clinically testable targets summarized in Appendix B.

6 Limitations and future directions

6.1 Conceptual simplifications

The ARCH × Φ model represents replication initiation as a threshold-governed system, reducing hundreds of biochemical reactions to four composite control variables. This abstraction clarifies the governing logic but omits the detailed feedback and post-translational regulation operating within each domain [9], [10], [11], [12, 23]. In vivo, A, D, C, and Φ are interdependent: metabolic signaling affects chromatin accessibility, and checkpoint activation modifies both licensing and drive. The framework should therefore be viewed as a first-order conditional scaffold for organizing these interrelations rather than a full mechanistic map.

6.2 Quantitative parameterization

Implementing the model requires empirical scaling of each variable (0–1) and estimation of the threshold T. A can be quantified by genome-wide ORC/MCM occupancy or licensing-factor abundance [9], 10]; D by CDK activity assays and nucleotide-pool measurements [11], 12]; C by ATAC-seq or histone-mark profiling [13], 14]; and Φ by checkpoint or cyclin-phosphorylation readouts [15], 24]. Defining T involves correlating these normalized metrics with replication onset at single-cell resolution, potentially using logistic regression or control-system identification methods [28], 29]. Until such calibration is achieved, predictions remain qualitative, but the model’s structure offers a practical roadmap for parameter extraction.

6.3 Integration with stochastic and dynamical frameworks

Future extensions should express the model as a time-dependent system, dR/dt = f(Φ, A, D, C) − g(R), where f represents activation and g denotes inhibitory feedback. This formulation enables the simulation of replication kinetics and the stability analysis using established nonlinear and delay-differential methods [28], [29], [30]. Adding stochastic noise terms could capture the heterogeneity observed in origin firing and S-phase duration [33], 34], 36], thereby linking the conceptual and quantitative domains for direct comparison with single-cell data.

6.4 Multiscale extensions

The same governing logic can be applied hierarchically. At the sub-nuclear scale, each origin has local A, D, C, and Φ values; at the cellular level, these aggregate into a replication probability; and across tissues, the averaged Φ reflects the developmental or pathological state. Embedding ARCH × Φ within agent-based or network models would allow exploration of how replication-timing domains arise from local interactions. This multiscale view aligns with systems-biology efforts to integrate chromatin architecture, metabolism, and cell-cycle control within unified dynamic frameworks [5], 32], 42].

6.5 Experimental roadmap

Empirical testing may proceed in three stages:

  1. Perturbation matrix experiments: systematically vary A (MCM or ORC knockdown), D (CDK or nucleotide modulation), and C (chromatin accessibility) while monitoring replication entry [19], 21]; fit initiation frequencies to the predicted multiplicative model.

  2. Single-cell correlation analysis: quantify each parameter by live-cell reporters or multiplexed imaging and regress replication onset against Φ(A × D × C); a sigmoidal relationship would confirm the threshold hypothesis.

  3. Dynamic control testing: use optogenetic or chemical tools to modulate Φ transiently and demonstrate reversible threshold crossing in real time [24], 38].

These experiments would transform the model from a qualitative synthesis into a quantitatively testable framework.

6.6 Broader theoretical implications

The gating architecture described here may extend beyond replication to other conditionally executed cellular programs – such as transcriptional activation, immune signaling, or developmental fate transitions [5], 39], 42]. In each, structural readiness, metabolic drive, contextual modulation, and phase alignment act conjunctively to determine execution. Integrating these processes within the same ARCH grammar could yield a scalable framework for biological decision-making across molecular, cellular, and behavioral levels.

7 Discussion and broader implications

7.1 Conceptual integration

The ARCH × Φ model reframes DNA-replication initiation as a conditionally gated event rather than a linear biochemical cascade. It unifies structural licensing, metabolic drive, chromatin context, and phase control within one quantitative framework, explaining both complete inhibition when any prerequisite is missing and synergistic suppression under partial perturbation [11], 20], 21]. The model formalizes the long-recognized all-or-none nature of S-phase entry within a mathematical architecture consistent with control theory and systems biology principles [28], [29], [30], linking empirical molecular biology to the general logic of nonlinear systems analysis.

7.2 Relationship to existing paradigms

Classical models, such as the Rb–E2F feedback switch, describe G 1/S commitment as a bistable transition driven by reciprocal activation and inhibition [16], 31], 32]. ARCH × Φ generalizes this behavior by embedding bistability within a broader conjunctive manifold: replication begins only when readiness across all four domains exceeds threshold. Unlike additive or feedback-only schemes, this framework captures conditional necessity – each control axis is indispensable – thereby integrating feedback kinetics, probabilistic origin firing, and structural licensing within a unified grammar of control.

7.3 Evolutionary and cross-scale continuity

The progressive coupling of A, D, C, and Φ likely reflects an evolutionary deepening of control – from prebiotic replication governed by passive energetic constraints to eukaryotic systems in which initiation became an information-driven decision. The ARCH × Φ framework thus outlines a conserved decision grammar elaborated rather than replaced through evolution.

Replication control exemplifies a universal principle: complex acts occur only when multiple constraints align. The same logic governs behavior at higher levels of organization – from neural reflexes to multicellular coordination. Extending the original ARCH behavioral model [6] to the molecular scale reveals a shared computational architecture for conditional activation; replication initiation becomes the cellular analogue of behavioral execution, both rooted in structural readiness, energetic drive, contextual modulation, and systemic control. Energetic optimization likely reinforced this architecture. Primitive systems replicated whenever conditions coincided, regardless of cost, whereas modern cells integrate energetic expense into the decision, initiating only when investment yields functional benefit. This shift from permissive to efficient convergence represents a further evolutionary refinement of the ARCH × Φ logic.

7.4 Theoretical implications for systems biology

Framing replication as a gated nonlinear system embeds it within the broader landscape of biological control. Such representation enables stability analysis, bifurcation mapping, and predictive simulation long used in engineering but underapplied in cell biology [28], 29]. Replication exemplifies a bistable switch: the system remains non-replicating until the control surface is crossed, after which it transitions to a stable replicating state. This dual-state topology parallels phase transitions in physics and decision thresholds in neural circuits [7], 8], 16], providing a quantitative bridge between molecular regulation and nonlinear dynamics.

7.5 Implications for disease, therapeutics, and synthetic biology

Pathological and engineered states can be viewed as distortions – or deliberate manipulations – of the ARCH × Φ balance. In cancer, oncogenic signaling elevates D and Φ while chromatin dysregulation or licensing defects reduce A and C; replication persists above threshold, producing genomic instability [39], 40]. Therapeutic strategies that jointly attenuate D (CDK inhibition) and restore C (chromatin-stabilizing or checkpoint-restoring agents) could lower overall readiness and suppress tumor proliferation. Conversely, synthetic or minimal cells deliberately maintain high D and permissive Φ under simplified constraints to accelerate replication. These contrasting regimes illustrate the model’s predictive reach and its utility for designing multi-target interventions or controllable self-replicating systems, as summarized in Appendix B.

7.6 Generalization beyond DNA replication

Threshold-governed dynamics likely extend to other organellar and cellular programs. For instance, mitochondrial biogenesis requires the alignment of structural, energetic, contextual, and phase factors: A (the mitochondrial apparatus, including mitochondrial DNA and transcription factor A, mitochondrial – TFAM), D (energetic and signaling inputs such as the adenosine monophosphate/adenosine triphosphate ratio and activation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha – PGC-1α), C (nuclear–mitochondrial coordination, proteostasis, and membrane dynamics), and Φ (global permissivity, reflecting cell-cycle phase or stress checkpoints). Disruption of any component – such as TFAM deletion, suppression of AMP-activated protein kinase (AMPK), or chromatin closure of oxidative phosphorylation (OXPHOS) genes – abolishes biogenesis despite other terms remaining intact. This mirrors the “zero-term veto” observed in apoptosis, where loss of the pro-apoptotic B-cell lymphoma 2 (Bcl-2) family proteins Bcl-2-associated X protein (Bax) and Bcl-2 antagonist/killer 1 (Bak) prevents mitochondrial outer membrane permeabilization even under maximal pro-death drive. Similar conjunctive logic may govern transcriptional bursts, immune activation, differentiation, and behavioral outputs [5], [42], [43], [44]. Recognizing this shared control grammar could yield a unified, scale-invariant theory of biological execution, consistent with the view that life organizes information through hierarchical, threshold-based systems rather than linear causal chains.

7.7 Summary of theoretical perspective

The ARCH × Φ model provides a concise yet comprehensive framework for replication initiation, consolidating diverse empirical findings into a single governing equation. It explains bistability and synergistic inhibition without invoking complex feedback circuits and situates replication within a universal theory of biological behavior. Because its predictions are experimentally falsifiable through multifactor perturbations of A, D, C, and Φ, the model offers a tractable basis for quantitative testing and for extending control-theoretic analysis across biological scales – from genome duplication to cognition.

8 Conclusions

The ARCH × Φ model reframes DNA-replication initiation as a conditionally gated, threshold-driven decision rather than a linear biochemical sequence. Replication commences only when architectural integrity (A), metabolic drive (D), chromatin context (C), and phase control (Φ) align above a critical readiness threshold. This framework unites structural, metabolic, and regulatory determinants within a single quantitative expression, accounting for bistability, synergistic inhibition, and once-per-cycle fidelity without requiring complex feedback networks. Extending the validated ARCH behavioral framework from neural systems to molecular replication exposes a common decision logic operating across biological scales. The model transforms replication from a descriptive molecular process into a falsifiable, predictive system – one that links cellular control to general principles of nonlinear dynamics and decision theory. Its implications extend beyond genomics, offering a quantitative language for understanding dysregulated replication in cancer, designing multi-target therapeutics, and engineering controllable self-replicating systems. In essence, ARCH × Φ defines replication as a universal decision principle of living matter, where structure, energy, context, and control must converge for life to act.


Corresponding author: Tahir Rahman, School of Medicine, Alvin J. Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO, USA, E-mail:

  1. Funding information: Authors state no funding involved.

  2. Conflict of interest: Authors state no conflict of interest.

  3. Data availability statement: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

  4. AI Assistance: Portions of this manuscript (grammar, editing, formatting, and figure layout) were refined using OpenAI’s ChatGPT system under the author’s direction. The AI tool was used solely to assist with language clarity, figure design alignment, and equation formatting. All conceptual, analytical, and scientific content, including hypotheses, data interpretation, and conclusions, were developed and verified entirely by the author. The author assumes full responsibility for the integrity and originality of the scientific content.

Appendix A: Mathematical formulation and normalization

A.1 Model definition

Replication initiation is represented as a threshold-governed multiplicative system:

R t = Φ t × A t × D t × C t ,

where A(t), D(t), C(t), and Φ(t) ∈ [0,1] are normalized state variables that vary continuously in time. Replication proceeds when R(t) ≥ T, with T denoting the critical threshold for activation. Each variable represents a distinct control domain:

Appendix Table: Model Variable Definitions.

Variable Definition Typical empirical range
A Origin licensing and molecular architecture 0–1; approaches 1 in late G 1
D Metabolic/kinase drive 0–1; threshold ≈0.6
C Chromatin/contextual accessibility 0–1; domain-dependent
Φ Global phase-control readiness 0–1; ≈1 in late G 1/S

A.2 Time-dependent formulation

To analyze dynamical properties, the steady-state relation can be extended to a differential form:

d R / d t = k 1 × Φ t × A t D t C t k 2 × R t ,

where k1 is the activation rate constant and k2 represents deactivation or inhibitory decay (e.g., checkpoint enforcement). At equilibrium: R* = (k1/k2) × Φ(A D C). Replication is stable and sustained only when R* ≥ T. Linearization around R* yields the local stability condition: d(dR/dt)/dR|R* = −k2 < 0, indicating that once initiated, the system relaxes toward a stable steady state until one or more variables decrease below threshold.

A.3 Threshold surface and stability

The critical surface separating replicative from non-replicative states is defined by Φ(A D C) = T. For Φ fixed, this surface partitions the three-dimensional ADC space into stable (R > T) and inactive (R < T) domains. Differentiation of the activation function gives:

R / A = Φ D C , R / D = Φ A C , R / C = Φ A D

This demonstrates mutual dependence: a decrement in any variable proportionally scales the effect of the others. Such multiplicative coupling produces nonlinear amplification and threshold phenomena characteristic of bistable biological switches.

A.4 Normalization procedure

Each variable may be normalized to its physiological range:

X norm t = X t X min / X max X min , X A , D , C , Φ

Normalization ensures comparability across experimental conditions and enables estimation of T as the point at which the measured replication probability transitions from 0 to 1. Single-cell data can be fitted to: P(replication) = 1/[1 + exp(−β[Φ(A D C) − T])], yielding β as the slope (steepness) of the activation curve.

A.5 Relation to stability theory

The threshold-crossing property conforms to the general structure of state-dependent switching systems described in nonlinear control theory. In such systems, stability is governed by Lyapunov functions whose derivatives change sign upon crossing the manifold Φ(A D C) = T. When R(t) < T, the system remains in the quiescent attractor; when R(t) > T, trajectories converge to the active attractor. This dual-state topology provides a formal justification for the empirical bistability of S-phase commitment. Hence, ARCH × Φ can be interpreted as a biological realization of a nonlinear control system, where architectural, metabolic, and chromatin terms act as multiplicative control inputs and Φ as a global gain or switching coefficient.

A.6 Implications for simulation

This formulation enables computational implementation using standard nonlinear-systems solvers. Sampling A, D, C, and Φ from empirical distributions and integrating the time-dependent equation reproduces population-level replication dynamics, bistability, and recovery after perturbation. These simulations can be compared with experimental datasets (e.g., single-cell Repli-Seq, chromatin-state maps) to infer parameter distributions and validate the theoretical threshold, T. References [28], [29], [30] correspond to established literature on nonlinear control and stability analysis. These predicted outcomes serve as testable benchmarks for future experiments, particularly in single-cell replication timing and checkpoint modulation studies. Each scenario provides a falsifiable prediction regarding the quantitative relationship among A, D, C, and Φ.

Appendix B

Key perturbation predictions derived from the ARCH × Φ framework. The table highlights expected replication outcomes and theoretical interpretations.

Condition Variable Configuration (A, D, C, Φ) Predicted product Φ(A × D × C) Expected outcome Experimental analog/validation Interpretation
Normal proliferating cell A ≈ 1, D ≈ 1, C ≈ 1, Φ ≈ 1 T Robust replication initiation (normal S phase). Standard cycling fibroblast or stem cell cultures. All control axes aligned above threshold → active replication.
Quiescent cell (G 0) A ≈ 1, D ≈ 0.2, C ≈ 0.6, Φ ≈ 0 <T Replication silent. Contact-inhibited or serum-starved fibroblasts. Low drive and Φ prevent activation despite intact licensing.
Checkpoint-activated cell A ≈ 1, D ≈ 0.4, C ≈ 0.6, Φ ≈ 0.3 <T Replication arrests until repair is complete. Hydroxyurea, ATR/ATM activation assays. Checkpoint signaling suppresses Φ and D below threshold.
Chromatin-compacted domain A ≈ 1, D ≈ 1, C ≈ 0.2, Φ ≈ 1 <T locally Late or suppressed origin firing. Heterochromatin regions; lamina-associated domains. Low chromatin accessibility reduces local C and delays initiation.
Embryonic/oncogenic cell A ≈ 0.8, D ≈ 1.2, C ≈ 1, Φ ≈ 1.2 T Accelerated or unscheduled replication. Embryonic stem cells; tumor cells with high CDK and relaxed checkpoints. Excessive drive and Φ overcome partial structural deficits → replication stress.
Partial perturbations (A↓, D↓) A = 0.5, D = 0.5, C = 1, Φ = 1 =0.25 < T Replication fails despite moderate depletion. Dual inhibition: ORC depletion + CDK inhibitor. Multiplicative synergy → supra-additive suppression of replication.
Checkpoint recovery A ≈ 1, D↑, C ≈ 0.6, Φ↑ Crosses T Replication restarts post-stress. Release from hydroxyurea block or DNA-damage recovery. Increasing D and Φ re-align the system above the threshold.
  1. Abbreviations for Appendix B table: A, archetype; D, drive; C, culture (chromatin/contextual accessibility); Φ, chase control; T, threshold constant for initiation; ↑/↓, increase or decrease relative to normal values; ≫T, product greatly exceeds threshold; <T, product below threshold. ORC, origin recognition complex; MCM, minichromosome maintenance helicase; CDK, cyclin-dependent kinase; ATR/ATM, ataxia telangiectasia and Rad3-related/ataxia telangiectasia mutated kinases; BrdU, bromodeoxyuridine.

References

1. Méndez, J, Stillman, B. Perpetuating the double helix: molecular machines at eukaryotic DNA replication origins. Bioessays 2003;25:1158–67. https://doi.org/10.1002/bies.10370.Search in Google Scholar PubMed

2. Watson, JD, Crick, FHC. Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature 1953;171:737–8. https://doi.org/10.1038/171737a0.Search in Google Scholar PubMed

3. Jacob, F, Brenner, S, Cuzin, F. On the regulation of DNA replication in bacteria. Cold Spring Harbor Symp Quant Biol 1963;28:329–48. https://doi.org/10.1101/SQB.1963.028.01.048.Search in Google Scholar

4. Ferrell, JEJr. Bistability, bifurcations, and Waddington’s epigenetic landscape. Curr Biol 2012;22:R458–66. https://doi.org/10.1016/j.cub.2012.03.045.Search in Google Scholar PubMed PubMed Central

5. Bertoli, C, Skotheim, JM, de Bruin, R. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol 2013;14:518–28. https://doi.org/10.1038/nrm3629.Search in Google Scholar PubMed PubMed Central

6. Rahman, T, Zorumski, CF, Meloy, JR. The ARCH model: a neuroevolutionary framework for behavioral execution. Front Psychiatry 2025;16:1669530. https://doi.org/10.3389/fpsyt.2025.1669530.Search in Google Scholar PubMed PubMed Central

7. Yao, G, Lee, TJ, Mori, S, Nevins, JR, You, L. A bistable Rb–E2F switch underlies the restriction point. Nat Cell Biol 2008;10:476–82. https://doi.org/10.1038/ncb1711.Search in Google Scholar PubMed

8. Ferrell, JEJr. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol 2002;14:140–8. https://doi.org/10.1016/S0955-0674(02)00314-9.Search in Google Scholar

9. Bell, SP, Dutta, A. DNA replication in eukaryotic cells. Annu Rev Biochem 2002;71:333–74. https://doi.org/10.1146/annurev.biochem.71.110601.135425.Search in Google Scholar PubMed

10. Bell, SP, Stillman, B. ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex. Nature 1992;357:128–34. https://doi.org/10.1038/357128a0.Search in Google Scholar PubMed

11. Sherr, CJ, Roberts, JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501–12. https://doi.org/10.1101/gad.13.12.1501.Search in Google Scholar PubMed

12. Aird, KM, Zhang, R. Nucleotide metabolism, oncogene-induced senescence and cancer. Cancer Lett 2015;356:204–10. https://doi.org/10.1016/j.canlet.2014.01.017.Search in Google Scholar PubMed PubMed Central

13. Bickmore, WA, van Steensel, B. Genome architecture: domain organization of interphase chromosomes. Cell 2013;152:1270–84. https://doi.org/10.1016/j.cell.2013.02.001.Search in Google Scholar PubMed

14. Pope, BD, Ryba, T, Dileep, V, Yue, F, Wu, W, Denas, O, et al.. Topologically associating domains are stable units of replication-timing regulation. Nature 2014;515:402–5. https://doi.org/10.1038/nature13986.Search in Google Scholar PubMed PubMed Central

15. Spencer, SL, Cappell, SD, Tsai, FC, Overton, KW, Wang, CL, Meyer, T. The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell 2013;155:369–83. https://doi.org/10.1016/j.cell.2013.08.062.Search in Google Scholar PubMed PubMed Central

16. Konagaya, Y, Rosenthal, D, Ratnayeke, N, Fan, Y, Meyer, T. An intermediate Rb–E2F activity state safeguards proliferation commitment. Nature 2024;631:424–31. https://doi.org/10.1038/s41586-024-07554-2.Search in Google Scholar PubMed PubMed Central

17. Shaltiel, IA, Krenning, L, Bruinsma, W, Medema, RH. The same, only different—DNA damage checkpoints and their reversal throughout the cell cycle. J Cell Sci 2015;128:607–20. https://doi.org/10.1242/jcs.163766.Search in Google Scholar PubMed

18. Rao, PN, Johnson, RT. Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature 1970;225:159–64. https://doi.org/10.1038/225159a0.Search in Google Scholar PubMed

19. Santocanale, C, Diffley, JFX. A Mec1- and Rad53-dependent checkpoint controls late-firing origins of DNA replication. Nature 1998;395:615–18. https://doi.org/10.1038/27001.Search in Google Scholar PubMed

20. Ferrell, JEJr., Ha, SH. Ultrasensitivity part II: multisite phosphorylation, stoichiometric inhibitors, and positive feedback. Trends Biochem Sci 2014;39:556–69. https://doi.org/10.1016/j.tibs.2014.09.003.Search in Google Scholar PubMed PubMed Central

21. Hiraga, SI, Ly, T, Garzón, J, Hořejší, Z, Ohkubo, YN, Endo, A, et al.. Human RIF1 and protein phosphatase 1 stimulate origin licensing but suppress origin activation. EMBO Rep 2017;18:403–19. https://doi.org/10.15252/embr.201641983.Search in Google Scholar PubMed PubMed Central

22. Rhind, N, Yang, SCH, Bechhoefer, J. Reconciling stochastic origin firing with defined replication timing. Chromosome Res 2010;18:35–43. https://doi.org/10.1007/s10577-009-9093-3.Search in Google Scholar PubMed PubMed Central

23. Blow, JJ, Laskey, RA. A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature 1988;332:546–8. https://doi.org/10.1038/332546a0.Search in Google Scholar PubMed

24. Joo, YK, Ramirez, C, Kabeche, L. A TRilogy of ATR’s non-canonical roles throughout the cell cycle and its relation to cancer. Cancers 2024;16:3536. https://doi.org/10.3390/cancers16203536.Search in Google Scholar PubMed PubMed Central

25. Mattarocci, S, Shyian, M, Lemmens, L, Damay, P, Altintas, DM, Shi, T, et al.. Rif1 controls DNA replication timing in yeast through the PP1 phosphatase Glc7. Cell Rep 2014;7:62–9. https://doi.org/10.1016/j.celrep.2014.03.010.Search in Google Scholar PubMed

26. Nakatani, T, Schauer, T, Altamirano-Pacheco, L, Klein, KN, Ettinger, A, Pal, M, et al.. Emergence of replication timing during early mammalian development. Nature 2024;625:401–9. https://doi.org/10.1038/s41586-023-06872-1.Search in Google Scholar PubMed PubMed Central

27. Bartlett, DA, Dileep, V, Baslan, T, Gilbert, DM. Mapping replication timing in single mammalian cells. Curr Protoc 2022;2:e334. https://doi.org/10.1002/cpz1.334.Search in Google Scholar PubMed PubMed Central

28. Michiels, W, Niculescu, SI. Stability and stabilization of time-delay systems: an eigenvalue-based approach. Society for Industrial and Applied Mathematics; 2007.10.1137/1.9780898718645Search in Google Scholar

29. Liberzon, D. Switching in systems and control. Boston: Birkhauser; 2003.10.1007/978-1-4612-0017-8Search in Google Scholar

30. Sontag, ED. Monotone and near-monotone biochemical networks. Syst Synth Biol 2007;1:59–87. https://doi.org/10.1007/s11693-007-9005-9.Search in Google Scholar PubMed PubMed Central

31. Tyson, JJ, Novak, B. Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J Theor Biol 2001;210:249–63. https://doi.org/10.1006/jtbi.2001.2293.Search in Google Scholar PubMed

32. Novak, B, Tyson, JJ. Numerical analysis of a comprehensive model of M-phase control in xenopus oocyte extracts and intact embryos. J Cell Sci 1993;106:1153–68. https://doi.org/10.1242/jcs.106.4.1153.Search in Google Scholar PubMed

33. Gindin, Y, Valenzuela, MS, Aladjem, MI, Meltzer, PS, Bilke, S. A chromatin structure–based model accurately predicts DNA replication timing in human cells. Mol Syst Biol 2014;10:722. https://doi.org/10.1002/msb.134859.Search in Google Scholar PubMed PubMed Central

34. Gilbert, DM, Takebayashi, SI, Ryba, T, Lu, J, Pope, BD, Wilson, KA, et al.. Space and time in the nucleus developmental control of replication timing and chromosome architecture. Cold Spring Harbor Symp Quant Biol 2010;75:143–53. https://doi.org/10.1101/sqb.2010.75.011.Search in Google Scholar PubMed

35. Mansisidor, AR, Risca, VI. Chromatin accessibility: methods, mechanisms, and biological insights. Nucleus 2022;13:238–78. https://doi.org/10.1080/19491034.2022.2143106.Search in Google Scholar PubMed PubMed Central

36. Vouzas, AE, Gilbert, DM. Replication timing and transcriptional control: beyond cause and effect—part IV. Curr Opin Genet Dev 2023;79:102031. https://doi.org/10.1016/j.gde.2023.102031.Search in Google Scholar PubMed PubMed Central

37. Chen, Y, Liang, R, Li, Y, Jiang, L, Ma, D, Luo, Q, et al.. Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. Signal Transduction Targeted Ther 2024;9:340. https://doi.org/10.1038/s41392-024-02030-9.Search in Google Scholar PubMed PubMed Central

38. Blythe, SA, Wieschaus, EF. Coordinating cell cycle remodeling with transcriptional activation at the drosophila MBT. Curr Top Dev Biol 2015;113:113–48. https://doi.org/10.1016/bs.ctdb.2015.06.002.Search in Google Scholar PubMed

39. Mathews, CK. Deoxyribonucleotide metabolism, mutagenesis and cancer. Nat Rev Cancer 2015;15:528–39. https://doi.org/10.1038/nrc3981.Search in Google Scholar PubMed

40. Hills, SA, Diffley, JFX. DNA replication and oncogene-induced replicative stress. Curr Biol 2014;24:R435–44. https://doi.org/10.1016/j.cub.2014.04.012.Search in Google Scholar PubMed

41. Scarpulla, RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008;88:611–38. https://doi.org/10.1152/physrev.00025.2007.Search in Google Scholar PubMed

42. Chakraborty, D, Rengaswamy, R, Raman, K. Designing biological circuits: from principles to applications. ACS Synth Biol 2022;11:1377–88. https://doi.org/10.1021/acssynbio.1c00557.Search in Google Scholar PubMed

43. Tait, SWG, Green, DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010;11:621–32. https://doi.org/10.1038/nrm2952.Search in Google Scholar PubMed

44. Petermann, E, Helleday, T. Pathways of mammalian replication fork restart. Nat Rev Mol Cell Biol 2010;11:683–7. https://doi.org/10.1038/nrm2974.Search in Google Scholar PubMed

Received: 2025-08-28
Accepted: 2025-11-03
Published Online: 2025-12-30

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Safety assessment and modulation of hepatic CYP3A4 and UGT enzymes by Glycyrrhiza glabra aqueous extract in female Sprague–Dawley rats
  2. Adult-onset Still’s disease with hemophagocytic lymphohistiocytosis and minimal change disease
  3. Role of DZ2002 in reducing corneal graft rejection in rats by influencing Th17 activation via inhibition of the PI3K/AKT pathway and downregulation of TRAF1
  4. Biomedical Sciences
  5. Mechanism of triptolide regulating proliferation and apoptosis of hepatoma cells by inhibiting JAK/STAT pathway
  6. Maslinic acid improves mitochondrial function and inhibits oxidative stress and autophagy in human gastric smooth muscle cells
  7. Comparative analysis of inflammatory biomarkers for the diagnosis of neonatal sepsis: IL-6, IL-8, SAA, CRP, and PCT
  8. Post-pandemic insights on COVID-19 and premature ovarian insufficiency
  9. Proteome differences of dental stem cells between permanent and deciduous teeth by data-independent acquisition proteomics
  10. Optimizing a modified cetyltrimethylammonium bromide protocol for fungal DNA extraction: Insights from multilocus gene amplification
  11. Preliminary analysis of the role of small hepatitis B surface proteins mutations in the pathogenesis of occult hepatitis B infection via the endoplasmic reticulum stress-induced UPR-ERAD pathway
  12. Efficacy of alginate-coated gold nanoparticles against antibiotics-resistant Staphylococcus and Streptococcus pathogens of acne origins
  13. Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–B-escin conjugates as SARS-CoV-2 inhibitors
  14. Neurodegenerative diseases and neuroinflammation-induced apoptosis
  15. Impact of fracture fixation surgery on cognitive function and the gut microbiota in mice with a history of stroke
  16. COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways
  17. High-temperature requirement serine protease A2 inhibitor UCF-101 ameliorates damaged neurons in traumatic brain-injured rats by the AMPK/NF-κB pathway
  18. SIK1 inhibits IL-1β-stimulated cartilage apoptosis and inflammation in vitro through the CRTC2/CREB1 signaling
  19. Rutin–chitooligosaccharide complex: Comprehensive evaluation of its anti-inflammatory and analgesic properties in vitro and in vivo
  20. Knockdown of Aurora kinase B alleviates high glucose-triggered trophoblast cells damage and inflammation during gestational diabetes
  21. Calcium-sensing receptors promoted Homer1 expression and osteogenic differentiation in bone marrow mesenchymal stem cells
  22. ABI3BP can inhibit the proliferation, invasion, and epithelial–mesenchymal transition of non-small-cell lung cancer cells
  23. Changes in blood glucose and metabolism in hyperuricemia mice
  24. Rapid detection of the GJB2 c.235delC mutation based on CRISPR-Cas13a combined with lateral flow dipstick
  25. IL-11 promotes Ang II-induced autophagy inhibition and mitochondrial dysfunction in atrial fibroblasts
  26. Short-chain fatty acid attenuates intestinal inflammation by regulation of gut microbial composition in antibiotic-associated diarrhea
  27. Application of metagenomic next-generation sequencing in the diagnosis of pathogens in patients with diabetes complicated by community-acquired pneumonia
  28. NAT10 promotes radiotherapy resistance in non-small cell lung cancer by regulating KPNB1-mediated PD-L1 nuclear translocation
  29. Phytol-mixed micelles alleviate dexamethasone-induced osteoporosis in zebrafish: Activation of the MMP3–OPN–MAPK pathway-mediating bone remodeling
  30. Association between TGF-β1 and β-catenin expression in the vaginal wall of patients with pelvic organ prolapse
  31. Primary pleomorphic liposarcoma involving bilateral ovaries: Case report and literature review
  32. Effects of de novo donor-specific Class I and II antibodies on graft outcomes after liver transplantation: A pilot cohort study
  33. Sleep architecture in Alzheimer’s disease continuum: The deep sleep question
  34. Ephedra fragilis plant extract: A groundbreaking corrosion inhibitor for mild steel in acidic environments – electrochemical, EDX, DFT, and Monte Carlo studies
  35. Langerhans cell histiocytosis in an adult patient with upper jaw and pulmonary involvement: A case report
  36. Inhibition of mast cell activation by Jaranol-targeted Pirin ameliorates allergic responses in mouse allergic rhinitis
  37. Aeromonas veronii-induced septic arthritis of the hip in a child with acute lymphoblastic leukemia
  38. Clusterin activates the heat shock response via the PI3K/Akt pathway to protect cardiomyocytes from high-temperature-induced apoptosis
  39. Research progress on fecal microbiota transplantation in tumor prevention and treatment
  40. Low-pressure exposure influences the development of HAPE
  41. Stigmasterol alleviates endplate chondrocyte degeneration through inducing mitophagy by enhancing PINK1 mRNA acetylation via the ESR1/NAT10 axis
  42. AKAP12, mediated by transcription factor 21, inhibits cell proliferation, metastasis, and glycolysis in lung squamous cell carcinoma
  43. Association between PAX9 or MSX1 gene polymorphism and tooth agenesis risk: A meta-analysis
  44. A case of bloodstream infection caused by Neisseria gonorrhoeae
  45. Case of nasopharyngeal tuberculosis complicated with cervical lymph node and pulmonary tuberculosis
  46. p-Cymene inhibits pro-fibrotic and inflammatory mediators to prevent hepatic dysfunction
  47. GFPT2 promotes paclitaxel resistance in epithelial ovarian cancer cells via activating NF-κB signaling pathway
  48. Transfer RNA-derived fragment tRF-36 modulates varicose vein progression via human vascular smooth muscle cell Notch signaling
  49. RTA-408 attenuates the hepatic ischemia reperfusion injury in mice possibly by activating the Nrf2/HO-1 signaling pathway
  50. Decreased serum TIMP4 levels in patients with rheumatoid arthritis
  51. Sirt1 protects lupus nephritis by inhibiting the NLRP3 signaling pathway in human glomerular mesangial cells
  52. Sodium butyrate aids brain injury repair in neonatal rats
  53. Interaction of MTHFR polymorphism with PAX1 methylation in cervical cancer
  54. Convallatoxin inhibits proliferation and angiogenesis of glioma cells via regulating JAK/STAT3 pathway
  55. The effect of the PKR inhibitor, 2-aminopurine, on the replication of influenza A virus, and segment 8 mRNA splicing
  56. Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  57. Small cell lung cancer with small intestinal metastasis: Case report and literature review
  58. GRB14: A prognostic biomarker driving tumor progression in gastric cancer through the PI3K/AKT signaling pathway by interacting with COBLL1
  59. 15-Lipoxygenase-2 deficiency induces foam cell formation that can be restored by salidroside through the inhibition of arachidonic acid effects
  60. FTO alleviated the diabetic nephropathy progression by regulating the N6-methyladenosine levels of DACT1
  61. Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study
  62. Zinc valproic acid complex promotes osteoblast differentiation and exhibits anti-osteoporotic potential
  63. Primary pulmonary synovial sarcoma in the bronchial cavity: A case report
  64. Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
  65. Uterine tumor resembling ovarian sex cord tumor with extensive rhabdoid differentiation: A case report
  66. Genomic analysis of a novel ST11(PR34365) Clostridioides difficile strain isolated from the human fecal of a CDI patient in Guizhou, China
  67. Effects of tiered cardiac rehabilitation on CRP, TNF-α, and physical endurance in older adults with coronary heart disease
  68. Changes in T-lymphocyte subpopulations in patients with colorectal cancer before and after acupoint catgut embedding acupuncture observation
  69. Modulating the tumor microenvironment: The role of traditional Chinese medicine in improving lung cancer treatment
  70. Alterations of metabolites related to microbiota–gut–brain axis in plasma of colon cancer, esophageal cancer, stomach cancer, and lung cancer patients
  71. Research on individualized drug sensitivity detection technology based on bio-3D printing technology for precision treatment of gastrointestinal stromal tumors
  72. CEBPB promotes ulcerative colitis-associated colorectal cancer by stimulating tumor growth and activating the NF-κB/STAT3 signaling pathway
  73. Oncolytic bacteria: A revolutionary approach to cancer therapy
  74. A de novo meningioma with rapid growth: A possible malignancy imposter?
  75. Diagnosis of secondary tuberculosis infection in an asymptomatic elderly with cancer using next-generation sequencing: Case report
  76. Hesperidin and its zinc(ii) complex enhance osteoblast differentiation and bone formation: In vitro and in vivo evaluations
  77. Research progress on the regulation of autophagy in cardiovascular diseases by chemokines
  78. Anti-arthritic, immunomodulatory, and inflammatory regulation by the benzimidazole derivative BMZ-AD: Insights from an FCA-induced rat model
  79. Immunoassay for pyruvate kinase M1/2 as an Alzheimer’s biomarker in CSF
  80. The role of HDAC11 in age-related hearing loss: Mechanisms and therapeutic implications
  81. Evaluation and application analysis of animal models of PIPNP based on data mining
  82. Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
  83. Fabrication of zinc oxide nanoparticles using Ruellia tuberosa leaf extract induces apoptosis through P53 and STAT3 signalling pathways in prostate cancer cells
  84. Haplo-hematopoietic stem cell transplantation and immunoradiotherapy for severe aplastic anemia complicated with nasopharyngeal carcinoma: A case report
  85. Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
  86. The expression of epidermal growth factor receptor 2 and its relationship with tumor-infiltrating lymphocytes and clinical pathological features in breast cancer patients
  87. Innovations in MALDI-TOF Mass Spectrometry: Bridging modern diagnostics and historical insights
  88. BAP1 complexes with YY1 and RBBP7 and its downstream targets in ccRCC cells
  89. Hypereosinophilic syndrome with elevated IgG4 and T-cell clonality: A report of two cases
  90. Electroacupuncture alleviates sciatic nerve injury in sciatica rats by regulating BDNF and NGF levels, myelin sheath degradation, and autophagy
  91. Polydatin prevents cholesterol gallstone formation by regulating cholesterol metabolism via PPAR-γ signaling
  92. RNF144A and RNF144B: Important molecules for health
  93. Analysis of the detection rate and related factors of thyroid nodules in the healthy population
  94. Artesunate inhibits hepatocellular carcinoma cell migration and invasion through OGA-mediated O-GlcNAcylation of ZEB1
  95. Endovascular management of post-pancreatectomy hemorrhage caused by a hepatic artery pseudoaneurysm: Case report and review of the literature
  96. Efficacy and safety of anti-PD-1/PD-L1 antibodies in patients with relapsed refractory diffuse large B-cell lymphoma: A meta-analysis
  97. SATB2 promotes humeral fracture healing in rats by activating the PI3K/AKT pathway
  98. Overexpression of the ferroptosis-related gene, NFS1, corresponds to gastric cancer growth and tumor immune infiltration
  99. Understanding risk factors and prognosis in diabetic foot ulcers
  100. Atractylenolide I alleviates the experimental allergic response in mice by suppressing TLR4/NF-kB/NLRP3 signalling
  101. FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells
  102. Immune molecule diagnostics in colorectal cancer: CCL2 and CXCL11
  103. Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
  104. Cadmium toxicity, health risk and its remediation using low-cost biochar adsorbents
  105. Pulmonary cryptococcosis with headache as the first presentation: A case report
  106. Solitary pulmonary metastasis with cystic airspaces in colon cancer: A rare case report
  107. RUNX1 promotes denervation-induced muscle atrophy by activating the JUNB/NF-κB pathway and driving M1 macrophage polarization
  108. Morphometric analysis and immunobiological investigation of Indigofera oblongifolia on the infected lung with Plasmodium chabaudi
  109. The NuA4/TIP60 histone-modifying complex and Hr78 modulate the Lobe2 mutant eye phenotype
  110. Experimental study on salmon demineralized bone matrix loaded with recombinant human bone morphogenetic protein-2: In vitro and in vivo study
  111. A case of IgA nephropathy treated with a combination of telitacicept and half-dose glucocorticoids
  112. Analgesic and toxicological evaluation of cannabidiol-rich Moroccan Cannabis sativa L. (Khardala variety) extract: Evidence from an in vivo and in silico study
  113. Wound healing and signaling pathways
  114. Combination of immunotherapy and whole-brain radiotherapy on prognosis of patients with multiple brain metastases: A retrospective cohort study
  115. To explore the relationship between endometrial hyperemia and polycystic ovary syndrome
  116. Research progress on the impact of curcumin on immune responses in breast cancer
  117. Biogenic Cu/Ni nanotherapeutics from Descurainia sophia (L.) Webb ex Prantl seeds for the treatment of lung cancer
  118. Dapagliflozin attenuates atrial fibrosis via the HMGB1/RAGE pathway in atrial fibrillation rats
  119. Glycitein alleviates inflammation and apoptosis in keratinocytes via ROS-associated PI3K–Akt signalling pathway
  120. ADH5 inhibits proliferation but promotes EMT in non-small cell lung cancer cell through activating Smad2/Smad3
  121. Apoptotic efficacies of AgNPs formulated by Syzygium aromaticum leaf extract on 32D-FLT3-ITD human leukemia cell line with PI3K/AKT/mTOR signaling pathway
  122. Novel cuproptosis-related genes C1QBP and PFKP identified as prognostic and therapeutic targets in lung adenocarcinoma
  123. Bee venom promotes exosome secretion and alters miRNA cargo in T cells
  124. Treatment of pure red cell aplasia in a chronic kidney disease patient with roxadustat: A case report
  125. Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status
  126. Kynurenine facilitates renal cell carcinoma progression by suppressing M2 macrophage pyroptosis through inhibition of CASP1 cleavage
  127. RFX5 promotes the growth, motility, and inhibits apoptosis of gastric adenocarcinoma cells through the SIRT1/AMPK axis
  128. ALKBH5 exacerbates early cardiac damage after radiotherapy for breast cancer via m6A demethylation of TLR4
  129. Phytochemicals of Roman chamomile: Antioxidant, anti-aging, and whitening activities of distillation residues
  130. Circadian gene Cry1 inhibits the tumorigenicity of hepatocellular carcinoma by the BAX/BCL2-mediated apoptosis pathway
  131. The TNFR-RIPK1/RIPK3 signalling pathway mediates the effect of lanthanum on necroptosis of nerve cells
  132. Longitudinal monitoring of autoantibody dynamics in patients with early-stage non-small-cell lung cancer undergoing surgery
  133. The potential role of rutin, a flavonoid, in the management of cancer through modulation of cell signaling pathways
  134. Construction of pectinase gene engineering microbe and its application in tobacco sheets
  135. Construction of a microbial abundance prognostic scoring model based on intratumoral microbial data for predicting the prognosis of lung squamous cell carcinoma
  136. Sepsis complicated by haemophagocytic lymphohistiocytosis triggered by methicillin-resistant Staphylococcus aureus and human herpesvirus 8 in an immunocompromised elderly patient: A case report
  137. Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions
  138. Advances in cancer immunotherapy and future directions in personalized medicine
  139. Can coronavirus disease 2019 affect male fertility or cause spontaneous abortion? A two-sample Mendelian randomization analysis
  140. Heat stroke associated with novel leukaemia inhibitory factor receptor gene variant in a Chinese infant
  141. PSME2 exacerbates ulcerative colitis by disrupting intestinal barrier function and promoting autophagy-dependent inflammation
  142. Hyperosmolar hyperglycemic state with severe hypernatremia coexisting with central diabetes insipidus: A case report and literature review
  143. Efficacy and mechanism of escin in improving the tissue microenvironment of blood vessel walls via anti-inflammatory and anticoagulant effects: Implications for clinical practice
  144. Merkel cell carcinoma: Clinicopathological analysis of three patients and literature review
  145. Genetic variants in VWF exon 26 and their implications for type 1 Von Willebrand disease in a Saudi Arabian population
  146. Lipoxin A4 improves myocardial ischemia/reperfusion injury through the Notch1-Nrf2 signaling pathway
  147. High levels of EPHB2 expression predict a poor prognosis and promote tumor progression in endometrial cancer
  148. Knockdown of SHP-2 delays renal tubular epithelial cell injury in diabetic nephropathy by inhibiting NLRP3 inflammasome-mediated pyroptosis
  149. Exploring the toxicity mechanisms and detoxification methods of Rhizoma Paridis
  150. Concomitant gastric carcinoma and primary hepatic angiosarcoma in a patient: A case report
  151. YAP1 inhibition protects retinal vascular endothelial cells under high glucose by inhibiting autophagy
  152. Identification of secretory protein related biomarkers for primary biliary cholangitis based on machine learning and experimental validation
  153. Integrated genomic and clinical modeling for prognostic assessment of radiotherapy response in rectal neoplasms
  154. Stem cell-based approaches for glaucoma treatment: a mini review
  155. Bacteriophage titering by optical density means: KOTE assays
  156. Neutrophil-related signature characterizes immune landscape and predicts prognosis of esophageal squamous cell carcinoma
  157. Integrated bioinformatic analysis and machine learning strategies to identify new potential immune biomarkers for Alzheimer’s disease and their targeting prediction with geniposide
  158. TRIM21 accelerates ferroptosis in intervertebral disc degeneration by promoting SLC7A11 ubiquitination and degradation
  159. TRIM21 accelerates ferroptosis in intervertebral disc degeneration by promoting SLC7A11 ubiquitination and degradation
  160. Histone modification and non-coding RNAs in skin aging: emerging therapeutic avenues
  161. A multiplicative behavioral model of DNA replication initiation in cells
  162. Biogenic gold nanoparticles synthesized from Pergularia daemia leaves: a novel approach for nasopharyngeal carcinoma therapy
  163. Creutzfeldt-Jakob disease mimicking Hashimoto’s encephalopathy: steroid response followed by decline
  164. Impact of semaphorin, Sema3F, on the gene transcription and protein expression of CREB and its binding protein CREBBP in primary hippocampal neurons of rats
  165. Iron overloaded M0 macrophages regulate hematopoietic stem cell proliferation and senescence via the Nrf2/Keap1/HO-1 pathway
  166. Revisiting the link between NADPH oxidase p22phox C242T polymorphism and ischemic stroke risk: an updated meta-analysis
  167. Exercise training preferentially modulates α1D-adrenergic receptor expression in peripheral arteries of hypertensive rats
  168. Overexpression of HE4/WFDC2 gene in mice leads to keratitis and corneal opacity
  169. Tumoral calcinosis complicating CKD-MBD in hemodialysis: a case report
  170. Mechanism of KLF4 Inhibition of epithelial-mesenchymal transition in gastric cancer cells
  171. Dissecting the molecular mechanisms of T cell infiltration in psoriatic lesions via cell-cell communication and regulatory network analysis
  172. Circadian rhythm-based prognostic features predict immune infiltration and tumor microenvironment in molecular subtypes of hepatocellular carcinoma
  173. Ecology and Environmental Science
  174. Optimization and comparative study of Bacillus consortia for cellulolytic potential and cellulase enzyme activity
  175. The complete mitochondrial genome analysis of Haemaphysalis hystricis Supino, 1897 (Ixodida: Ixodidae) and its phylogenetic implications
  176. Epidemiological characteristics and risk factors analysis of multidrug-resistant tuberculosis among tuberculosis population in Huzhou City, Eastern China
  177. Indices of human impacts on landscapes: How do they reflect the proportions of natural habitats?
  178. Genetic analysis of the Siberian flying squirrel population in the northern Changbai Mountains, Northeast China: Insights into population status and conservation
  179. Diversity and environmental drivers of Suillus communities in Pinus sylvestris var. mongolica forests of Inner Mongolia
  180. Global assessment of the fate of nitrogen deposition in forest ecosystems: Insights from 15N tracer studies
  181. Fungal and bacterial pathogenic co-infections mainly lead to the assembly of microbial community in tobacco stems
  182. Influencing of coal industry related airborne particulate matter on ocular surface tear film injury and inflammatory factor expression in Sprague-Dawley rats
  183. Temperature-dependent development, predation, and life table of Sphaerophoria macrogaster (Thomson) (Diptera: Syrphidae) feeding on Myzus persicae (Sulzer) (Homoptera: Aphididae)
  184. Eleonora’s falcon trophic interactions with insects within its breeding range: A systematic review
  185. Agriculture
  186. Integrated analysis of transcriptome, sRNAome, and degradome involved in the drought-response of maize Zhengdan958
  187. Variation in flower frost tolerance among seven apple cultivars and transcriptome response patterns in two contrastingly frost-tolerant selected cultivars
  188. Heritability of durable resistance to stripe rust in bread wheat (Triticum aestivum L.)
  189. Molecular mechanism of follicular development in laying hens based on the regulation of water metabolism
  190. Molecular identification and control studies on Coridius sp. (Hemiptera: Dinidoridae) in Al-Khamra, south of Jeddah, Saudi Arabia
  191. 10.1515/biol-2025-1218
  192. Animal Science
  193. Effect of sex ratio on the life history traits of an important invasive species, Spodoptera frugiperda
  194. Plant Sciences
  195. Hairpin in a haystack: In silico identification and characterization of plant-conserved microRNA in Rafflesiaceae
  196. Widely targeted metabolomics of different tissues in Rubus corchorifolius
  197. The complete chloroplast genome of Gerbera piloselloides (L.) Cass., 1820 (Carduoideae, Asteraceae) and its phylogenetic analysis
  198. Field trial to correlate mineral solubilization activity of Pseudomonas aeruginosa and biochemical content of groundnut plants
  199. Correlation analysis between semen routine parameters and sperm DNA fragmentation index in patients with semen non-liquefaction: A retrospective study
  200. Plasticity of the anatomical traits of Rhododendron L. (Ericaceae) leaves and its implications in adaptation to the plateau environment
  201. Effects of Piriformospora indica and arbuscular mycorrhizal fungus on growth and physiology of Moringa oleifera under low-temperature stress
  202. Effects of different sources of potassium fertiliser on yield, fruit quality and nutrient absorption in “Harward” kiwifruit (Actinidia deliciosa)
  203. Comparative efficiency and residue levels of spraying programs against powdery mildew in grape varieties
  204. The DREB7 transcription factor enhances salt tolerance in soybean plants under salt stress
  205. Using plant electrical signals of water hyacinth (Eichhornia crassipes) for water pollution monitoring
  206. Response of hybrid grapes (Vitis spp.) to two biotic stress factors and their seedlessness status
  207. Metabolomic profiling reveals systemic metabolic reprogramming in Alternaria alternata under salt stress
  208. Effects of mixed salinity and alkali stress on photosynthetic characteristics and PEPC gene expression of vegetable soybean seedlings
  209. Food Science
  210. Phytochemical analysis of Stachys iva: Discovering the optimal extract conditions and its bioactive compounds
  211. Review on role of honey in disease prevention and treatment through modulation of biological activities
  212. Computational analysis of polymorphic residues in maltose and maltotriose transporters of a wild Saccharomyces cerevisiae strain
  213. Optimization of phenolic compound extraction from Tunisian squash by-products: A sustainable approach for antioxidant and antibacterial applications
  214. Liupao tea aqueous extract alleviates dextran sulfate sodium-induced ulcerative colitis in rats by modulating the gut microbiota
  215. Toxicological qualities and detoxification trends of fruit by-products for valorization: A review
  216. Polyphenolic spectrum of cornelian cherry fruits and their health-promoting effect
  217. Optimizing the encapsulation of the refined extract of squash peels for functional food applications: A sustainable approach to reduce food waste
  218. Advancements in curcuminoid formulations: An update on bioavailability enhancement strategies curcuminoid bioavailability and formulations
  219. Impact of saline sprouting on antioxidant properties and bioactive compounds in chia seeds
  220. The dilemma of food genetics and improvement
  221. Causal effects of trace elements on congenital foot deformities and their subtypes: a Mendelian randomization study with gut microbiota mediation
  222. Honey meets acidity: a novel biopreservative approach against foodborne pathogens
  223. Bioengineering and Biotechnology
  224. Impact of hyaluronic acid-modified hafnium metalorganic frameworks containing rhynchophylline on Alzheimer’s disease
  225. Emerging patterns in nanoparticle-based therapeutic approaches for rheumatoid arthritis: A comprehensive bibliometric and visual analysis spanning two decades
  226. Application of CRISPR/Cas gene editing for infectious disease control in poultry
  227. Preparation of hafnium nitride-coated titanium implants by magnetron sputtering technology and evaluation of their antibacterial properties and biocompatibility
  228. Preparation and characterization of lemongrass oil nanoemulsion: Antimicrobial, antibiofilm, antioxidant, and anticancer activities
  229. Fluorescent detection of sialic acid–binding lectins using functionalized quantum dots in ELISA format
  230. Smart tectorigenin-loaded ZnO hydrogel nanocomposites for targeted wound healing: synthesis, characterization, and biological evaluation
  231. Corrigendum
  232. Corrigendum to “Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells”
  233. Corrigendum to “Effects of Ire1 gene on virulence and pathogenicity of Candida albicans
  234. Retraction
  235. Retraction of “Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer”
Downloaded on 14.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2025-1229/html
Scroll to top button